SCHEMBL10241074

SCHEMBL10241074

CC(C)(C)N1CCNc2ccccc2C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.54
HPGD P15428 2/20 0.39
BRD4 O60885 1/20 0.39
CREBBP Q92793 1/20 0.39
AHR P35869 1/20 0.36
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
OPRM1 P35372 1/20 0.35
GRIN1 Q05586 1/20 0.35
KCNH2 Q12809 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
AVPR1A P37288 1/20 0.33
CYP2B6 P20813 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7005533 0.80 MAPK1 (0.45) MAPK1HPGDBRD4CREBBPAHR
SCHEMBL2849413 0.77 MAOA (0.53) MAPK1HPGDBRD4CREBBPAHR
SCHEMBL14192103 0.74 NPC1 (0.53) MAPK1BRD4CREBBPAHRACHE
SCHEMBL681107 0.74 GRIN2D (0.33) MAPK1GRIN2DGRIN3BCHRM2CHRM1
SCHEMBL19652058 0.73 MAPK1 (0.69) MAPK1HPGDAHRDPP4EPHX2
SCHEMBL14433009 0.73 MAPK1 (0.47) MAPK1HPGDBRD4CREBBPAHR
SCHEMBL861946 0.72 MAOA (0.44) HPGDGRIN2DGRIN3BCHRM2CHRM1
SCHEMBL10280392 0.72 MAPK1 (0.47) MAPK1HPGDBRD4CREBBPAHR
SCHEMBL12533132 0.72 MAPK1 (0.47) MAPK1HPGDBRD4CREBBPAHR
SCHEMBL861951 0.72 MAOA (0.57) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148422-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-03 US disclosed
US-20100160289-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160289-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM2, TRPM5 MAPK1 1742/4885HPGD 3801/4885BRD4 769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.